11 min reading time This email from group member Bill Vick deserves your attention and pass-along through email, LinkedIn, Facebook, and Twitter. He writes, “In September 2011 after months of tests, my physician gave me the news, “Bill, you have Idiopathic Pulmonary Fibrosis. There is no cure. You have about 3 years to live, so get your things in order.” My wife and I were in disbelief. Idiopathic Pulmonary Fibrosis? What is that? IPF is an irreversible and incurable lung disease. It kills the same number as breast cancer every year, but is relatively unheard of. Without any known cause, IPF starts with scarring of the lung and prohibits oxygen from moving into the bloodstream, making breathing difficult. After diagnoses, most live 3-5 years. I’ve been lucky, I’ve had 6 years, but I can feel its progress. Joe, consider this: You can start your car from your cell phone and set your DVR thousands of miles away, but when I need to turn up my oxygen tank, I get up, walk to another room and make an adjustment. Why is that still happening in this age of smart devices? Did you know for the most part, you can’t tell if oxygen is flowing through the tubes? Or that portable oxygen tanks don’t provide enough flow for most IPF patients to leave home, so many are home-bound? These problems are fixable with innovation and motivation. Please direct your group members to https://medgroup.biz/IPF. It links to the $1,000,000 IPF Catalyst Challenge, a competition for ideas to improve quality-of-life for IPF patients and families. The answer won’t come in my lifetime. But wouldn’t it be great if one of your readers suggests the breakthrough innovation we need? My thanks to you and those who respond to our message. Sincerely, Bill Vick” My dear readers, can you help – at least by spreading this message? Thank you. +++ Make it a great week. Joe Hage P.S. Virpi and Anne-Marie invented a device for cartilage repair in weight bearing joints. See https://medgroup.biz/COPLA Joe Hage Joe Hage Joe Hage Joe Hage One said, “Please let Bill know of a intratranstrachea cannula, cannula goes into the trach does not require high liter flow of oxygen during ambulation(this is when O2 sats dive). We did this a lot in the 90s. Only a few older pulmonogist that does this procedure on fibrosis patients.” And Steeve Asselin wrote, “It is indeed saddening to see how much innovation, sometime, is put in some seemingly ridicule things. But as an Industrial Technology Advisor for the NRC-IRAP in Canada I have the chance to meet many innovative SMEs in the medical devices sector. One of them, http://www.oxynov.com/en/, may have a technology that could help people suffering from the same illness as Mr. Vick. Not understanding exactly the needs of that specific population I cannot provide more. Please let them know you were informed of their product by me. Wishing the best finishing miles to Mr. Vick.” Joe Hage Joe Hage Richard Paul Perhaps 300k + Medical Devices group could organize a crowd source and crowd funding challenge— Similar to an X Prize —directed by members with strong expertise in the disease and relevant technology domains. A few Venture groups that may be interested in taking a position. There’s incredible research taking place in respiratory diseases around the world. An Israel team recently announced a number of new discoveries (bio-markers) for exhaled breath and treatments. There are a few teams in Silicon Valley working on organ forensics and research technologies focused on matching organ transplants for lower rates of rejections. We’ve been pursuing patents that were locked up by patent troll lawyers that are directly related to the elements of the disease and management. Keep the story fresh and I bet several contributors to the discovery process will arrive. Thanks to sharing Joe 👼 Don Smith Charlie Higgins John Eckberg Ash Taha MD Debbie Black Bill Vick Mary Audette Kris Simmons McCulloch Jeff Gaus Bill VickS Mark C Adams, MBA Scott Thielman Jackie Bojor Doreen Milford Meghan M. Alonso Michelle Springhorn Kingsbury Cherie B. Mathews Go to youtube, look up “weaponised mycoplasma” Dr Garth Nicholson, then study serrapeptase a systemic enzyme. Google serrapeptase /pulmonary fibrosis or serrapeptase copd they are very similar. Our lungs are being filled with fibrin. Serrapeptase a systemic enzyme tones down an over reactive immune system and literally eats the fibrin plugging your lungs. Serrapeptase also acts against biofilm and attacks mycoplasma. It destroys biofilm and eats foreign proteins found in your blood that germs require for replication. This is the only known way to stop the disease. Doctors give steroidal antiinflammatories for this condition. This increases the speed of disease progression since mycoplasma feeds off of preformed sterols. Next thing go to george eby research and spend a few days there studying gallium nitrate. These two things are 99 percent of what you need to reverse the disease. Other treatments that will help are uvbi, whole body blood ozonation, blood electrification or simply buy a hbot chamber. Blood ozonation kills the mycoplasma that drives the disease. Hbot only slaps it around a bit being much weaker than ozone. Once you learn about mineral solutions like gallium nitrate you will see it is able to help a wide variety of seeming totally unrelated diseases. For example pulmonary fibrosis, cancer, multiple sclerosis, lupus, crohns, various std’s, arthritis, and a mind boggling variety of other autoimmune diseases are all helped by one simple mineral solution, gallium nitrate. Yet 99.9% of the world has never heard of it. He perceives that this has improved his breathing, as before he was only able to climb 3 flights of stairs and now can do at least 5 flights of stairs. And the oxygen levels have improved, according to doctors tests. Richard Paul Perhaps the 300k + Medical Devices group could organize a crowd source and crowd funding challenge— Similar to an X Prize —directed by members with strong expertise in the disease and relevant technology domains. We could put you in touch with a few Venture groups that may be interested in taking a position. There’s incredible research taking place in respiratory diseases around the world. An Israel team recently announced a number of new discoveries (bio-markers) for exhaled breath and treatments. There are a few teams in Silicon Valley working on organ forensics and research technologies focused on matching organ transplants for lower rates of rejections. We’ve been pursuing patents that were locked up by patent troll lawyers that are directly related to the elements of the disease and management. Keep the story fresh and I bet several contributors to the discovery process will arrive. Keep up the great work Joe . Thanks for sharing. Robert Garvie Peter Rogal Melody Bullock, Infusion Science Specialist Anwar Abdullah Phyllis Jones Suresh Tiwari Ricardo Drugovich Dr. Joerg Poetzsch Kerry Mellin Elaine Iuanow, MD Guido Blödorn Diane Zeh Tolu P. Jo Ann V. Taimur Channa Rosanne Wilson, CLFP Jesus G. Robert Jacox Michael “Mac” MacCartney Johan Westermark Marie N. Paul Doolan Bill states that most portable gas cylinders fail to deliver sufficient flow. What O2 flow is required? Yudhvijay Nautiyal Daniel Couchman Kendall Helen Allton Joseph Hale, PhD Clarence Outland Jr, MBA Mateja Mlakar Krzisnik Marked as spam  Posted by Asked on August 22, 2017 12:32 pm 520 views |
Meet your next client here. Join our medical devices group community.
Please log in to post questions.
